| 期 |
标题 |
文件 |
| 卷 6, 编号 2 (2009) |
Arterial hypertension and sleep apnea in pediatrics: results of pilot trial |
|
|
Madaeva I., Shevyrtalova O., Dolgikh V., Madaeva I., Shevyrtalova O., Dolgich V.
|
| 卷 5, 编号 3 (2008) |
b-Adrenoblokator s unikal'nymi kharakteristikami - nebivolol |
|
|
Ratova L., Chazova I.
|
| 卷 9, 编号 4 (2012) |
B-ADRENOBLOCKERS IN THERAPY FOR ARTERIAL HYPERTENSION: ON THE WAY TO REASONABLE COMPROMISE |
|
|
Perepech N., Shurygina V.
|
| 卷 8, 编号 2 (2011) |
b-Adrenoblokatory vchera, segodnyai zavtra: smogut li oni ostat'syav gruppe osnovnykh lekarstvennykhsredstv? |
|
|
Fomin I., Polyakov D.
|
| 卷 14, 编号 3 (2017) |
Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease |
(Rus)
|
|
Fomin I., Polyakov D.
|
| 卷 11, 编号 3 (2014) |
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol |
(Rus)
|
|
Baryshnikov G., Stepanova I., Kudryavtseva N.
|
| 卷 6, 编号 4 (2009) |
Candesartan in the prevention of cardiovascular catastrophes: emphasis on the pre-vention of stroke |
|
|
Drapkina O., Dikur O.
|
| 卷 17, 编号 2 (2020) |
COVID-19: a patient with cardiovascular disease at high risk |
(Rus)
|
|
Chazova I., Zhernakova Y., Ostroumova O.
|
| 卷 10, 编号 3 (2013) |
Covremennye predstavleniya ob ideal'noy kombinatsii antigipertenzivnykh preparatov dlya profilaktiki insul'ta |
|
|
Ostroumova O., Fomina V., Guseva T.
|
| 卷 6, 编号 3 (2009) |
Efficacy of amlodipin in treatment of arterial hypertension. |
|
|
Prokhorovich E.
|
| 卷 6, 编号 4 (2009) |
Hypertension Summer School 19-25 September, 2009 - Smolenice, Slovakia |
|
|
Aksenova A.
|
| 卷 6, 编号 1 (2009) |
Metabolic syndrome |
|
|
Mychka V., Chazova I., Mychka V., Chazova I.
|
| 卷 8, 编号 3 (2011) |
-Blokatory - dokazano! |
|
|
Silina E., Aleksanyan L.
|
| 卷 13, 编号 3 (2016) |
Workplace hypertension": focus on emotional and personality traits in patients |
(Rus)
|
|
Ostroumova O., Pervichko E., Zinchenko Y.
|
| 卷 10, 编号 1 (2013) |
Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer |
|
|
Gilyarevsky S., Orlov V., Kuzmina I., Golshmid M.
|
| 卷 12, 编号 4 (2015) |
«New» molecules composed of rational combinations of antihypertensive drugs: issues of choice |
(Rus)
|
|
Kislyak O., Chervyakova Y.
|
| 卷 8, 编号 2 (2011) |
«Rozhdennyy» ASCOT |
|
|
Ostroumova O., Bondarets O.
|
| 卷 13, 编号 2 (2016) |
"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension |
(Rus)
|
|
Sagaydak O., Danilov N., Matchin Y., Martynyuk T., Chazova I.
|
| 卷 4, 编号 2 (2007) |
Β-ADRENOBLOKATORY: MESTO IKh PRIMENENIYa PRI ARTERIAL'NOY GIPERTONII V SOVREMENNYKh USLOVIYaKh |
|
|
Chazova I.
|
| 卷 11, 编号 1 (2014) |
Β-blockers: the lack of taskimplementation or the unwillingness of doctors in the russian federation to optimize the treatment? |
(Rus)
|
|
Fomin I., Polyakov D.
|
| 卷 8, 编号 3 (2011) |
Aktual'nye voprosy lecheniyaarterial'noy gipertenzii:fokus na kombinirovannuyu terapiyu |
|
|
Nebieridze D.
|
| 卷 11, 编号 4 (2014) |
Topical questions of beta-blockers application in clinical practice |
(Rus)
|
|
Nebieridze D.
|
| 卷 6, 编号 4 (2009) |
Topical problems in the clinical application of -adrenoblockers |
|
|
Nebieridze D.
|
| 卷 13, 编号 3 (2016) |
Main questions of β-blockers application in clinical practice: do they all the same? |
(Rus)
|
|
Nebieridze D.
|
| 卷 6, 编号 2 (2009) |
Amlodipin in the treatment of arterial hypertension |
|
|
Galyavich A.
|
| 卷 6, 编号 4 (2009) |
Amlodipine: its ability to reduce the risk of complications of arterial hypertension |
|
|
Runikhina N., Tkacheva O.
|
| 卷 9, 编号 4 (2012) |
Analysis of associations between genetic markers of erythrocytes of ав0, Rh, mn, P, kell blood group systems and arterial hypertension at the Altai Republic population |
|
|
Ogargov M., Mulerova T., Filimonov S., Luzina F., Onishchenko E.
|
| 卷 9, 编号 4 (2012) |
Analysis of antihypertensive therapy and its adherence in hypertensive patients with and without concomitant diabetes mellitus |
|
|
Sergeyeva V.
|
| 卷 2, 编号 1 (2005) |
Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA) |
|
|
Chazova I., Ratova L.
|
| 卷 13, 编号 2 (2016) |
Calcium antagonists in pharmacotherapy in patients with concomitant cardiac pathology: priorities of the recommendations in clinical practice |
(Rus)
|
|
Kompaniets O., Linchak R., Ketova G.
|
| 卷 6, 编号 3 (2009) |
Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan |
|
|
Vikulova O., Shestakova M.
|
| 卷 8, 编号 1 (2011) |
Antagonisty retseptorov k angiotenzinu II v 2010 g.: chto novogo? |
|
|
Ostroumova O., Maksimov M., Shchukina G., Shorikova E.
|
| 卷 15, 编号 1 (2018) |
Pulmonary hypertension: reasonable selection of specific therapy |
(Rus)
|
|
Karoli N., Sazhnova S., Rebrov A.
|
| 卷 7, 编号 4 (2010) |
Antigipertenzivnaya i kardioprotektivnaya effektivnost' lozartana u bol'nykh arterial'noy gipertenziey s gipertrofiey miokarda levogo zheludochka:rezul'taty dlitel'nogo (6-12 mes) nablyudeniya v usloviyakh poliklinicheskoy praktiki |
|
|
Chikhladze N., Sakhnova T., Blinova E., Yarovaya E., Chazova I.
|
| 卷 4, 编号 1 (2007) |
Antigipertenzivnaya terapiya vo vtorichnoy profilaktike |
|
|
Parfenov V., Starchina Y.
|
| 卷 7, 编号 2 (2010) |
Antigipertenzivnaya terapiya vo vtorichnoy profilaktike insul'ta i postinsul'tnoy dementsii |
|
|
Ostroumova O., Stepura O., Bondarets O., Guseva T.
|
| 卷 4, 编号 2 (2007) |
Antigipertenzivnaya terapiya: mesto nefiksirovannykh kombinatsiy preparatov |
|
|
Ratova L., Chazova I.
|
| 卷 5, 编号 4 (2008) |
Antigipertenzivnaya effektivnost' antagonistov kal'tsiya u bol'nykhs arterial'noy gipertoniey v zavisimosti ot riskaserdechno-sosudistykh oslozhneniy |
|
|
Chazova I., Ratova L., Galyavich A., Gapon L., Ivashkin V., Katel'nitskaya L., Martsevich S., Nedogoda S.
|
| 卷 1, 编号 1 (2004) |
Antigipertenzivnaya effektivnost' valsartana, vliyanie na sostoyanie tsentral'noy gemodinamiki i mikrotsirkulyatsii: vzglyad s pozitsiy organoprotektsii |
|
|
Podzolkov V., Bulatov V., Son E., Makolkin V.
|
| 卷 8, 编号 4 (2011) |
Antigipertenzivnaya effektivnost' irbesartana |
|
|
Ostroumova O., Shchukina G., Fomina V.
|
| 卷 5, 编号 2 (2008) |
Antigipertenzivnaya effektivnost' moksonidina u patsientov s ozhireniem i nekontroliruemoy arterial'noy gipertenziey |
|
|
Jose Abellan -., Mariano Leal -., Fernando Hernandez-Menarguez -., Jose A., Antonio Martinez-Pastor -., Soledad Garcia de Vinuesa -., Jose Luno -.
|
| 卷 10, 编号 1 (2013) |
Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension |
|
|
Glukhova T., Solgalova S., Alferov V.
|
| 卷 11, 编号 4 (2014) |
Arterial hypertension and brain damage. New targets of therapy |
(Rus)
|
|
Yanishevskiy S., Mirnaya D., Andreyev R.
|
| 卷 5, 编号 2 (2008) |
Arterial'naya gipertenziya i faktory serdechno-sosudistogo riska. Vozmozhnost' upravleniya situatsiey |
|
|
Volkova E.
|
| 卷 9, 编号 3 (2012) |
Arterial'naya gipertenziya pri ostrom insul'te - drug ili vrag? (Lektsiya) |
|
|
Tsarenko S.
|
| 卷 5, 编号 4 (2008) |
Arterial'naya gipertenziya u beremennykh |
|
|
Tkacheva O., Runikhina N., Mishina I., Barabashkina A.
|
| 卷 10, 编号 3 (2013) |
Arterial'naya gipertenziya u zhenshchin v postmenopauze: interv'yu s ekspertom |
|
|
Tkacheva O.
|
| 卷 7, 编号 1 (2010) |
Arterial'naya gipertenziya: znachenie individual'nogo vybora lekarstvennykh sredstv i mesto β-adrenoblokatorov |
|
|
Morozova T.
|
| 卷 9, 编号 1 (2012) |
Arterial'naya gipertoniya i bronkhoobstruktivnaya patologiya - osobennosti klinicheskoy kartiny |
|
|
Ratova L., Zykov K., Dolgusheva Y., Agapova O., Nazarov B., Chazova I.
|
| 卷 1, 编号 1 (2004) |
Arterial'naya gipertoniya i ishemicheskaya bolezn' serdtsa: poisk optimal'nykh podkhodov k lecheniyu (po rezul'tatam issledovaniya INVEST) |
|
|
Chazova I.
|
| 卷 4, 编号 2 (2007) |
Arterial'naya gipertoniya i postmenopauza: vozmozhnosti ingibitora angiotenzinprevrashchayushchego fermenta enalaprila |
|
|
Morozova T., Syumakova S.
|
| 卷 6, 编号 1 (2009) |
Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin |
|
|
Ezhov M., Yezhov M.
|
| 卷 2, 编号 2 (2005) |
Arterial'naya gipertoniya i tserebrovaskulyarnye narusheniya |
|
|
Skvortsova V.
|
| 卷 5, 编号 2 (2008) |
Arterial'naya gipertoniya, kurenie, pochki - chto obshchego? Rezul'taty issledovaniya IRIS |
|
|
Chazova I., Ratova L.
|
| 卷 5, 编号 1 (2008) |
Arterial'naya gipertoniya pri zabolevaniyakh shchitovidnoy zhelezy |
|
|
Mychka V., Chazova I.
|
| 卷 15, 编号 2 (2018) |
Arterial hypertension in patients with non-specific aortoarteritis |
(Rus)
|
|
Chikhladze N.
|
| 卷 12, 编号 1 (2015) |
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach |
(Rus)
|
|
Zhernakova Y., Sharipova G., Chazova I.
|
| 卷 6, 编号 4 (2009) |
Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia. |
|
|
Ostroumova O., Korsakova N., Varako N.
|
| 卷 4, 编号 1 (2007) |
Arterial'naya gipertoniya – mishen' dlya pervichnoy profilaktiki serdechno-sosudistykh zabolevaniy, obuslovlennykh aterosklerozom: est' li neobkhodimost' primenyat' statiny? |
|
|
Mamedov M.
|
| 卷 5, 编号 3 (2008) |
Arterial'naya gipotenziya kak faktor riska smertnosti |
|
|
Tyurina T.
|
| 卷 5, 编号 3 (2008) |
Arterial'naya gipotoniya u bol'nykh s vtorichnym giperal'dosteronizmom: sindromy Barttera i Gitel'mana |
|
|
Chikhladze N.
|
| 卷 18, 编号 1 (2021) |
Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II |
(Rus)
|
|
Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galyavich A., Rotar’ O., Khaisheva L., Kameneva T.
|
| 卷 12, 编号 2 (2015) |
Ser49Gly polymorphic markers associations of ADRB1 gene and 4a/4b eNOS gene with hypertension and ischemic heart disease among the population of mountain shoria natives |
(Rus)
|
|
Mulerova T., Rubtsova E., Kuz'mina A., Tatarnikova N., Maksimov V., Voevoda M., Ogarkov M.
|
| 卷 12, 编号 4 (2015) |
Association of clinical and genetic factors with left ventricular hypertrophy in hypertension among the indigenous population Mountain Shoria |
(Rus)
|
|
Mulerova T., Kuzmina A., Chigisova A., Voropaeva E., Maksimov V., Voevoda M., Ogarkov M.
|
| 卷 6, 编号 3 (2009) |
Atherosclerotic stenos of renal arteries at patients with diabetes mellitus and arterial hypertension. |
|
|
Fomin V., Moiseev S., Shvetsov M., Mukhin N.
|
| 卷 12, 编号 2 (2015) |
Autoregulation hemodynamics in pregnancies complicated by hypertensive disorders |
(Rus)
|
|
Makarov R., Kinzhalova S., Davydova N.
|
| 卷 14, 编号 1 (2017) |
Balloon angioplasty as an alternative to thromboendarterectomy for proximal pulmonary artery obstruction in a patient with chronic thromboembolic pulmonary hypertension: a case report |
(Rus)
|
|
Danilov N., Matchin Y., Iarovoi S., Demchenkova A., Chazova I.
|
| 卷 12, 编号 1 (2015) |
Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases |
(Rus)
|
|
Dolgusheva Y., Agapova O., Zykov K., Chazova I.
|
| 卷 5, 编号 1 (2008) |
Beta-blokatory v lechenii arterial'noy gipertonii,ili Velikobritaniya protiv ostal'noy Evropy |
|
|
Tereshchenko S., Zhirov I.
|
| 卷 15, 编号 2 (2018) |
Nitrogen oxide biochemical pathway in pulmonary arterial hypertension therapy and REPLACE trial results |
(Rus)
|
|
Shmalts A., Gorbachevsky S.
|
| 卷 14, 编号 1 (2017) |
Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application |
(Rus)
|
|
Maksimov M., Dralova O.
|
| 卷 7, 编号 4 (2010) |
Blokator retseptorov k angiotenzinu II v obespechenii arterial'noy normotenzii, adaptivnosti i komplaentnosti u patsientov s gipertonicheskoy bolezn'yu. |
|
|
Kompaniets O., Pokrovskiy V.
|
| 卷 3, 编号 1 (2006) |
Blokatory beta-adrenergicheskikh retseptorov v lechenii arterial'noy gipertenzii u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu |
|
|
Preobrazhenskiy D., Tarykina E., Sidorenko B., Ermakova T., Stetsenko T., Pataraya S.
|
| 卷 10, 编号 3 (2013) |
Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii |
|
|
Shilov A.
|
| 卷 12, 编号 2 (2015) |
Calcium channel blockers: more than 50 years on guard of health |
(Rus)
|
|
Chazova I., Zhernakova Y.
|
| 卷 5, 编号 1 (2008) |
Blokatory retseptorov angiotenzina II pokazany bol'shinstvu bol'nykh arterial'noy gipertenziey? |
|
|
Fomin V.
|
| 卷 2, 编号 2 (2005) |
Blokatory retseptorov angiotenzina II pri lechenii arterial'noy gipertonii |
|
|
Ol'binskaya L.
|
| 卷 11, 编号 3 (2014) |
Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan |
(Rus)
|
|
Trukhan D.
|
| 卷 3, 编号 1 (2006) |
Blokatory retseptorov k angiotenzinu II v lechenii diabeticheskoy nefropatii s pozitsiy dokazatel'noy meditsiny |
|
|
Shestakova M.
|
| 卷 2, 编号 2 (2005) |
Blokatory retseptorov k angiotenzinu II – osoznannyy vybor patsienta |
|
|
Chazova I., Ratova L., Kolos I.
|
| 卷 7, 编号 4 (2010) |
V kakikh klinicheskikh situatsiyakh tselesoobrazno vybrat' fiksirovannuyu kombinatsiyu -adrenoblokatora i digidropiridinovogoantagonista kal'tsiya v terapii arterial'noy gipertonii. |
|
|
Chazova I., Ratova L.
|
| 卷 8, 编号 3 (2011) |
V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii |
|
|
Chazova I., Martynyuk T., Ratova L.
|
| 卷 4, 编号 1 (2007) |
Vazorenal'naya gipertoniya |
|
|
Grinshteyn Y., Shabalin V.
|
| 卷 13, 编号 1 (2016) |
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension |
(Rus)
|
|
Valieva Z., Glukhova S., Martyniuk T., Chazova I.
|
| 卷 9, 编号 4 (2012) |
Diurnal blood pressure variability as a risk factor for complications of arterial hypertension |
|
|
Ostroumova O., Reznikova K.
|
| 卷 18, 编号 4 (2021) |
Blood pressure variability, endothelial dysfunction, and C-reactive protein levels in arterial hypertension in combination with coronary artery disease |
(Rus)
|
|
Musikhina N., Petelina T., Gapon L., Kostousova A.
|
| 卷 16, 编号 4 (2019) |
Heart rate variability in women with essential hypertension under exposure of regular moderate physical training |
(Rus)
|
|
Smolyakov Y., Kuznik B., Guseva E., Davydov S.
|
| 卷 8, 编号 4 (2011) |
Varianty formirovaniya metabolicheskogo sindroma s pozitsii faktornogo analiza |
|
|
Chernavskiy S., Fursov A., Potekhin N.
|
| 卷 5, 编号 3 (2008) |
Vedenie zhenshchin s serdechno-sosudistym riskom v peri- i postmenopauze: konsensus rossiyskikh kardiologov i ginekologov |
|
|
Chazova I., Smetnik V., Balan V., Zaydieva Y., Maychuk E., Mychka V., Kirichenko A., Podzolkov V., Podzolkova N., Yureneva S.
|
| 卷 18, 编号 3 (2021) |
Management of patients with arterial hypertension and atrial fibrillation |
(Rus)
|
|
Chazova I., Golitsyn S., Zhernakova J., Zheleznova E., Kropacheva E., Mironov N., Kostiukevich M., Laiovich L., Utsumueva M., Iuricheva I., Litvin A., Elfimova E., Rogoza A., Panchenko E.
|
| 卷 13, 编号 3 (2016) |
Prolonged release verapamil: application in clinical practice |
(Rus)
|
|
Gaponova N., Abdrakhmanov V.
|
| 卷 14, 编号 3 (2017) |
Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects |
(Rus)
|
|
Luchinina E., Kompaniets O., Kizhvatova N.
|
| 卷 14, 编号 4 (2017) |
Relationship between selected populations of leukocytes and cardiovascular system activity in women with essential hypertension |
(Rus)
|
|
Kuznik B., Davydov S., Guseva E., Stepanov A., Smolyakov Y., Tsybikov N., Fine I., Magen E.
|
| 卷 18, 编号 1 (2021) |
Effects of the b-blockers on the functional state of patients with ventricular arrhythmias |
(Rus)
|
|
Shubitidze I., Tregubov V.
|
| 卷 10, 编号 1 (2013) |
Effect of adrenalectomy on the condition of the myocardium and arteries in hypertensive patient with primary hyperaldosteronism |
|
|
Valieva Z., Chikhladze N., Sakhnova T., Blinova E., Panteleev I., Tripoten M., Balakhonova T., Chazova I.
|
| 卷 12, 编号 1 (2015) |
Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome |
(Rus)
|
|
Blinova N., Masenko V., Chazova I.
|
| 卷 8, 编号 4 (2011) |
Vliyanie anomal'noy zhary leta 2010 g. na sostoyanie zdorov'ya kardiologicheskikh bol'nykh i taktika praktikuyushchikh vrachey ambulatorno-poliklinicheskogo zvena (po dannym anketirovaniya 215 vrachey poliklinik Moskvy i Moskovskoy oblasti) |
|
|
Chazova I., Ageev F., Smirnova M., Galaninskiy P., Shal'nova S.
|
| 卷 10, 编号 2 (2013) |
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome |
|
|
Nedogoda S., Salasyuk A., Chalyabi T., Barykina I., Pocheptsov D., Ledyaeva A., Tsoma V., Chumachek E.
|
| 卷 14, 编号 1 (2017) |
The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension |
(Rus)
|
|
Elfimova E., Rvacheva A., Tripoten M., Pogorelova O., Balakhonova T., Zykov K., Litvin A.
|
| 卷 15, 编号 2 (2018) |
The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial |
(Rus)
|
|
Chazova I., Martynyuk T., Accetto R., Sirenko Y., Vincelj J., Widimsky J., Barbič-Žagar B., Arhipov M., Grinshtein Y., Ostroumova O., Galjavich A., Rotar O., Haisheva L., Nedogoda S.
|
| 1 - 100 的 734 信息 |
1 2 3 4 5 6 7 8 > >> |
